Mardi C. Dier

2012

In 2012, Mardi C. Dier earned a total compensation of $753.8K as Executive Vice President and Chief Financial Officer at Portola Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$68,625
Option Awards$357,904
Salary$326,795
Other$500
Total$753,824

Dier received $357.9K in option awards, accounting for 47% of the total pay in 2012.

Dier also received $68.6K in non-equity incentive plan, $326.8K in salary and $500 in other compensation.

Rankings

In 2012, Mardi C. Dier's compensation ranked 7,269th out of 11,487 executives tracked by ExecPay. In other words, Dier earned more than 36.7% of executives.

ClassificationRankingPercentile
All
7,269
out of 11,487
37th
Division
Manufacturing
2,603
out of 4,253
39th
Major group
Chemicals And Allied Products
666
out of 1,198
44th
Industry group
Drugs
460
out of 920
50th
Industry
Pharmaceutical Preparations
363
out of 700
48th
Source: SEC filing on April 30, 2015.

Dier's colleagues

We found two more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2012.

2012

William Lis

Portola Pharmaceuticals

Chief Executive Officer

2012

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

News

You may also like